In December 2025, pimicotinib was approved by the China National Medical Products Administration (NMPA) for the treatment of adult patients with symptomatic TGCT for which surgical resection will ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product ...

Discover how credit scores and credit reports differ, why each is important, and how they impact your financial life.

Higher pulse pressure was associated with greater progression of weight-bearing knee pain among adults with or at risk for knee OA.

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

A new study shows that clinician-supported self-management, but not spinal manipulation, is linked to greater improvement in disability from low back pain than recommended medical care.

CornerLoc™ today announced the publication of 6-month interim results from the SPARTAN Study, a prospective, multicenter clinical study designed to assess patient-reported pain and functional outcomes ...

EB3.Work explains how the 2026 Visa Bulletin impacts EB-3 priority dates, processing timelines, and long-term planning ...

KYMR rallied 82% in a year as KT-621 delivered strong phase Ib BroADen data and earned FDA Fast Track for atopic dermatitis.

Tralokinumab plus optional use of TCS or TCI in adults with moderate to severe AD was associated with stable disease control for up to 4 years.

Patients with primary biliary cholangitis and moderate-to-severe pruritus who received seladelpar over 6 months experienced a ...

OPM's plan to corral inflated performance ratings should also be mindful not to undercut employee excellence with arbitrary limits on recognition.